Anonymous donor gifts $50M to help University of Washington train ‘unsung heroes’ of healthcare
On Dec. 1, 2025, in an unusual act of philanthropy, an anonymous donor has committed more than $50…
Artificial Intelligence | Biology | Diagnostics | Disease | Medicine | Pharmaceutical | Therapeutics
MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
CDC | Clinical Research | HIV | Infectious Disease | Medicine | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Veterinary
U.S. Centers for Disease Control and Prevention to End Monkey Research Program
On Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
FDA Quietly Approves Denosumab Biosimilars, Issues Interchangeability for Others
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio for $4.9 billion
On Nov. 11, 2025, Pfizer and Metsera announced the companies have entered into a definitive agreement under which…
Biotechnology | FDA | Medicine | Therapeutics
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
On Nov. 6, 2025, Eli Lilly announced an agreement with the U.S. government to expand access to its…
FDA to Accelerate Biosimilar Development and Lower costs
On Oct. 29, 2025, the U.S. Food and Drug Administration (FDA) announced it is aiming to reduce the…
Setback for Roche in Natco Pharma case as India Supreme Court allows generic drug sales
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
Diagnostics | Disease | FDA | Medicine | Pharmaceutical | Therapeutics
FDA unveils drugs to receive expedited review in support of ‘national priorities’
On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…
Researchers Announce a phone book-sized surgical kit designed for the world’s most extreme environments
On Oct. 14, 2025, researchers Texas A&M University School of Engineering Medicine (EnMed) announced development of a portable…
AstraZeneca announces historic agreement with US Government to lower the cost of medicines for American patients
On Oct. 10, 2025, AstraZeneca announced a historic agreement with President Donald J. Trump’s administration to lower the…
Ypsomed to establish first U.S. manufacturing facility in North Carolina
On Oct. 10, 2025, Ypsomed announced it will establish its first manufacturing facility in the United States. The…
New University of Alberta health institute will help research breakthroughs reach patients sooner
On Sept. 15, 2025, the University of Alberta (U of A) announced the Dianne and Irving Kipnes Health…
MannKind to Acquire scPharmaceuticals for $360 million
On Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
MSDH Declares Public Health Emergency on Infant Mortality
On Aug. 21, 2025, the Mississippi State Department of Health (MSDH) declared a public health emergency in response…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Novo Nordisk lowers cost of Ozempic® to $499 per month for self-paying patients
On Aug. 18, 2025, Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type…
Lilly signs $1.3 billion deal with Superluminal to discover obesity medicines using AI
On Aug. 14, 2025, Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines…
Scripps Scientists build an “evolution engine” to rapidly reprogram proteins
On Aug. 7, 2025, research scientists at Scripps Research announced a new platform that enables fast, scalable protein…
Biology | Diagnostics | Disease | Medicine | Therapeutics
Most U.S. adults have hearts older than their actual age
On Jul. 30, 2025, a study led by Northwestern Medicine shows that most U.S. adults have a “heart…
Biotechnology | CMO | Medical Device | Medicine | Pharmaceutical | Vaccine
Simtra BioPharma Solutions Announces Strategic Purchase to Expand U.S. Manufacturing Capacity for Injectable Medicines
On Jul. 25, 2025, Simtra BioPharma announced the purchase from Cook Group of a 65-acre property (301 N….
Precision gene editing medicine makes history, and it’s just getting started
On Jun. 30, 2025, as in something out of science fiction, a team of researchers reached into the…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Dupixent approved in the U.S. as the only targeted medicine to treat patients with bullous pemphigoid
On Jun. 20, 2025, the US Food and Drug Administration (FDA) announced it has approved Dupixent (dupilumab) for…
Biotechnology | CDC | FDA | HIV | Infectious Disease | Medicine | Therapeutics
Yeztugo® (Lenacapavir) Is the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection
On Jun. 18, 2025, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo®…
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
On Jun. 18, 2025, SandboxAQ, an artificial intelligence startup spun out of Alphabet’s Google and backed by Nvidia…
‘Artificial pancreas’ transforming the lives of thousands of children and young people with type 1 diabetes
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…
Biotechnology | Disease | Medicine | Oncology | Therapeutics
UK Nice leads the way in approving breakthrough treatment for multiple myeloma
On Jun. 13, 2025, people in England will become the first in the world to receive belantamab mafodotin…
Dr. Delese Mimi Darko Appointed Inaugural Director General of the African Medicines Agency (AMA)
On Jun. 4, 2025, the Conference of State Parties (CoSP) of the African Medicines Agency (AMA) announced the…
Sanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening U.S. presence
On May 22, 2025, Sanofi announces the formal opening of the company’s new flagship U.S. offices, unveiling a…
Diagnostics | Disease | Infectious Disease | Medicine | Oncology | Rare Disease | Therapeutics | WHO
Global leaders reaffirm commitment to WHO with More Than US$ 170 million
On May 20, 2025, the World Health Organization (WHO) announced that world leaders pledged at least an additional…
Prime Medicine Announces Breakthrough Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
On May 19, 2025, Prime Medicine announced positive initial data from the first patient dosed in its ongoing…